ClinicalTrials.gg
CompletedNCT06123585Updated Nov 9, 2023

Artificial Intelligence (AI) Empowered Smile Simulations: Do They Accurately Predict Actual Post Treatment Outcomes

An interventional study of Invisalign® SmileView™ and Invisalign aligners in Malocclusion, sponsored by Nourhan M.Aly. Completed at 1 site in United Arab Emirates. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-11-09.

Sponsored by Nourhan M.Aly · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 5 years 10 months after the study started (first participant enrolled Jan 2018, registered Nov 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the present study is to assess the predictability of Invisalign® SmileView™ for digital AI smile simulation in comparison to actual smile treatment outcomes, using various smile assessment parameters.

02

Conditions studied

  • Malocclusion

Browse trials for

03

In context

Malocclusion

469 studies on the registry are indexed under Malocclusion; 91 are open to participants now.

This study's enrollment of 24 is below the median of 36 across 383 interventional studies indexed under Malocclusion.

Browse Malocclusion studies →

Lead sponsor

Nourhan M.Aly is the lead sponsor of 49 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • healthy systemic condition with no chronic diseases
  • no previous orthodontic treatment
  • adequate oral hygiene
  • a healthy periodontium.

Exclusion criteria

Exclusion Criteria:

  • chronic diseases
  • previous orthodontic treatment
  • poor oral hygiene
  • periodontal diseases
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Invisalign® SmileView™

    Other: Invisalign® SmileView™

  • Active comparator
    Invisalign aligners

    Other: Invisalign aligners

Interventions

  • OtherInvisalign® SmileView™

    Pretreatment smiles were captured using the Invisalign® SmileView™ to simulate their new smiles before treatment was started.

  • OtherInvisalign aligners

    Patients were then treated using upper and lower Invisalign aligners with average treatment time of 12±3 months.

06

What researchers measure

Primary outcomes

  1. Smile line

    The extent of the vertical tooth display on smiling or the elevation of the upper lip in relation to the maxillary incisors. Three types of smile lines have been described- high, average, and low. A high smile shows the maxillary anterior teeth along with a significant amount of gingiva, an average smile shows maxillary anterior teeth with only interproximal gingiva, and a low smile typically shows less than two-thirds of the maxillary anterior teeth

    Time frame: through study completion, an average of 1 year

  2. Smile arc

    The relationship between the curvature of the maxillary anterior teeth and upper border of the lower lip. It is defined by drawing a line along the maxillary central incisal edges to the cusp tips of maxillary canines, which is related to another line drawn across the superior border of the lower lip. In subjects whose maxillary teeth are covered by lower lip, smile arc is designated as "not available". Three types of smile arcs have been described- "parallel to the teeth" (when the two lines follow the same curvature) also called a consonant smile, and a non-consonant smile, if the two lines are not parallel. A non-consonant smile can either be "straight" (with flatter curvature of the maxillary anterior teeth in relation to the lower lip) or "reverse" (when the maxillary anterior teeth form a reverse curve in relation to lower lip).

    Time frame: through study completion, an average of 1 year

  3. The most posterior teeth displayed

    Smiles are categorized as displaying teeth up to the canines, first premolars, second premolars, or the first molars. A tooth is counted when more than half of its surface is visible.

    Time frame: through study completion, an average of 1 year

  4. The philtrum height

    Distance measured in millimeters from subspinale (the base of the nose at the midline) to the most inferior portion of the upper lip on the vermilion tip beneath the philtral columns

    Time frame: through study completion, an average of 1 year

  5. Commissure height

    Distance measured in millimeters from a line constructed from the alar bases through subspinale and then from the commissures perpendicular to this line. The differential lip growth exhibits the difference in height in philtrum and commissural height in adolescents.

    Time frame: through study completion, an average of 1 year

  6. Smile width/Inter-commissure width

    The distance (mm) from outer commissure to outer commissure on smile in millimeters.

    Time frame: through study completion, an average of 1 year

  7. Smile index

    The ratio between the horizontal smile width and the vertical smile height during smiling (smile width/smile height).

    Time frame: through study completion, an average of 1 year

  8. Maxillary inter-canine width

    distance from the distal aspect of the right canine to the distal aspect of the left canine in millimeters

    Time frame: through study completion, an average of 1 year

  9. Buccal corridor

    It is the space created between the buccal surface of the posterior teeth and the lip corners when the patient smiles. Orthodontists often refer to buccal corridors as "negative spaces". The buccal corridor is measured from the mesial line angle of the maxillary first premolars to the interior portion of the commissure of the lips. Moore et al \[16\]. have previously quantified a buccal corridor of 28% as medium-narrow, 15% as medium, 10% as medium-broad, and 2% as broad smile fullness

    Time frame: through study completion, an average of 1 year

  10. Amount of lower incisor show

    The amount of lower incisor display which can be categorized into either 1) No show of lower incisors during smiling, 2) partial lower incisor exposure or 3) full length lower incisor exposure.

    Time frame: through study completion, an average of 1 year

07

Study locations

1 site
  • Private orthodontic offices of Invisalign Diamond Plus Elite
    Dubai, United Arab Emirates
08

References and documents

Publications

  • Adel SM, Bichu YM, Pandian SM, Sabouni W, Shah C, Vaiid N. Clinical audit of an artificial intelligence (AI) empowered smile simulation system: a prospective clinical trial. Sci Rep. 2024 Aug 21;14(1):19385. doi: 10.1038/s41598-024-69314-6. PubMed 39169095 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2018 to primary completion in Jul 2020, 30 months.

Of 260 non-industry interventional studies with no phase under Malocclusion, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 25. This study's 30 months is above that.

Counting every sponsor, half of 272 studies reached it within 15 months; a quarter within 10 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 1, 2023
First posted
Nov 9, 2023
StartActual
Jan 1, 2018
Primary completionActual
Jul 1, 2020
CompletionActual
Jul 5, 2020
Last update
Nov 9, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 9, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06123585
Lead sponsor
Nourhan M.Aly
Responsible party
Nourhan M.Aly (Assistant Lecturer of Dental Public Health, University of Alexandria) — Sponsor-investigator
First posted
Nov 9, 2023
Start date
Jan 1, 2018
Primary completion
Jul 1, 2020
Completion
Jul 5, 2020
Last update
Nov 9, 2023

Study contacts

Samar M Adel, PhD
principal investigator · Alexandria University
Yashodhan M Bichu, DSATP
study chair · Faculty of Dentistry, University of British Columbia, Vancouver, Canada
Srirengalakshmi Muthuswamy Pandian, PhD
study chair · Saveetha Dental College, Saveetha Insitute of Medical and Technical Sciences, Chennai, India.
Waddah Sabouni
study chair · Private Practice, Invisalign Centre Dubai United Arab Emirates.
Chandani Shah
study chair · Private practice, Mumbai, India
Nikhillesh Vaid, PhD
study chair · Saveetha Dental College, Saveetha Insitute of Medical and Technical Sciences, Chennai, India.

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion